In this study, a combination approach involving macroporous resin (MR) column chromatography and gradient countercurrent chromatography (CCC) was employed to enrich and purify bufadienolides from the roots and rhizomes of Helleborus thibetanus Franch. Initially, a D101 MR‐packed column chromatography was utilized for fractionation and enrichment of the bufadienolides, which were effectively eluted from the column using a 60% ethanol solution. CCC was subsequently introduced to separate the enriched product using the ethyl acetate/ n ‐butanol/water (EBuWat, 4:1:5, v/v) and EBuWat (5:0:5, v/v) solvent systems in a gradient elution mode. As results, five bufadienolides, including 6.1 mg of hellebrigenin‐3‐O‐ β ‐D‐glucoside ( 1 ), 2.2 mg of tigencaoside A ( 2 ), 8.3 mg of deglucohellebrin ( 3 ), 3.5 mg of 14 β‐hydroxy‐3β‐[β‐D‐glucopyranosyl‐(1→6)‐(β‐D‐glucopyranosyl)oxy]‐5α‐bufa‐20,22‐dienolide ( 4 ), and 3.0 mg of 14β‐hydroxy‐3β‐[(β‐D‐glucopyranosyl)oxy]‐5α‐bufa‐20,22‐dienolide ( 5 ), were effectively separated from 300 mg of the enriched product. The respective high‐performance liquid chromatography purities were as follows: 95.2%, 75.8%, 85.7%, 82.3%, and 92.8%. This study provides valuable insights for the efficient enrichment and separation of bufadienolides from Helleborus thibetanus Franch.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: